October 2025
The global minimal residual disease (MRD) testing market size is estimated to hit around USD 4.72 billion by 2034 increasing from USD 1.70 billion in 2025, with a CAGR of 12.00%.
April 2026
The global enteric disease testing market size was evaluated at USD 4.30 billion in 2025 and is predicted to hit around USD 8.09 billion by 2035, growing at a CAGR of 6.52%.
January 2025
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
August 2025
The global mosquito-borne infections testing market size was estimated at USD 27.11 billion in 2024 and is expected to hit around USD 39.52 billion by 2034, growing at a CAGR of 3.84%.
July 2025
The biological safety testing market size was evaluated at USD 4.85 billion in 2024 and is predicted to surpass around USD 17.00 billion by 2034, with a CAGR of 13.36%.
June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
June 2026
The global prenatal and newborn genetic testing market size is projected to hit around USD 30.94 billion by 2035, increasing from USD 9.28 billion in 2025, with at a solid CAGR of 12.8%.
June 2026
The non-destructive testing (NDT) market size accounted for USD 22.29 billion in 2025 and is expected to hit around USD 56.23 billion by 2035 with a CAGR of 9.69%.
June 2026
The global rapid microbiology testing market size is expected to increase to USD 12.72 billion by 2035 from USD 6.75 billion in 2025 with a notable CAGR of 6.54%.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
June 2026
The global Huntingtons disease market size was evaluated at USD 1.42 billion in 2025 and is predicted to hit around USD 6.48 billion by 2035, growing at a CAGR of 17.20%.
June 2026
The global hemoglobin A1c testing devices market size is estimated to hit around USD 4.72 billion by 2035 from USD 2.52 billion in 2025, with a CAGR of 6.48%.
June 2026
The global toxicology testing services market size is estimated to surpass around USD 70.78 billion by 2035 from USD 41.24 billion in 2025, with a CAGR of 5.55%.
June 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 3.75 billion in 2025 with a CAGR of 15.48%.
June 2026
The global arbovirus testing market size was evaluated at USD 1.35 billion in 2025 and is predicted to hit around USD 2.16 billion by 2035, growing at a CAGR of 4.80%.
May 2026
The global preterm birth and PROM testing market size is projected to hit around USD 3.70 billion by 2035 from USD 1.68 billion in 2025 with a CAGR of 8.22%.
May 2026
The global microbiology testing market size reached USD 6.31 billion in 2025 and is projected to be worth around USD 14.74 billion by 2035 with a CAGR of 8.85%.
May 2026
The infectious respiratory disease diagnostics market size is projected to hit around USD 96.57 billion by 2035 from USD 57.55 billion in 2025 with a CAGR of 5.31%.
May 2026
The global endocrine testing market size was estimated at USD 15.63 billion in 2025 and is expected to surge around USD 35.43 billion by 2035 with a CAGR of 8.53%.
May 2026
The global disease management apps market size is calculated at USD 10.20 billion in 2025 and is projected to hit around USD 27 billion by 2035 with a CAGR of 10.22%.
May 2026
The blood coagulation testing market size is calculated at USD 4.53 billion in 2025 and is expected to hit around USD 8.15 billion by 2035 with a CAGR of 6.05%.
May 2026
The global diabetic kidney disease market size was valued at USD 3.25 billion in 2025 and is projected to hit around USD 5.23 billion by 2035 with a CAGR of 4.87%.
May 2026
The global graves disease (overactive thyroid) market size is estimated to hit around USD 3.69 billion by 2035 increasing from USD 2.26 billion in 2025, with a CAGR of 5.02%.
May 2026
The global Alzheimers disease diagnostics market size was evaluated at USD 9.40 billion in 2025 and is predicted to hit around USD 26.21 billion by 2035, growing at a CAGR of 10.80%.
May 2026
The global Parkinsons disease biomarkers market size was evaluated at USD 1.35 billion in 2025 and is predicted to hit around USD 4.88 billion by 2035, growing at a CAGR of 13.80%.
May 2026
The global esoteric testing market size is estimated at USD 37.08 billion in 2025 and is predicted to hit around USD 100.94 billion by 2035 with a CAGR of 10.53%.
April 2026
The global inflammatory bowel disease treatment market size is projected to hit around USD 32.46 billion by 2035 from USD 22.38 billion in 2025, with a CAGR of 3.79%.
April 2026
The global metabolic testing equipment market size is projected to hit around USD 4.38 billion by 2035, increasing from USD 1.90 billion in 2025, growing at a CAGR of 8.70%.
April 2026
The global inflammatory disease market size was evaluated at USD 125.00 billion in 2025 and is predicted to hit around USD 241.34 billion by 2035, growing at a CAGR of 6.80%.
April 2026
The global GMO Testing market size was evaluated at USD 1.48 billion in 2025 and is predicted to hit around USD 3.72 billion by 2035, growing at a CAGR of 9.65%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com